Mutations in the cystic fibrosis
transmembrane conductance regulator
(CFTR) ion channel are established as the primary causative factor
in the devastating lung disease cystic fibrosis (CF). More recently,
cigarette smoke exposure has been shown to be associated with dysfunctional
airway epithelial ion transport, suggesting a role for CFTR in the
pathogenesis of chronic obstructive pulmonary disease (COPD). Here,
the identification and characterization of a high throughput screening
hit 6 as a potentiator of mutant human F508del and wild-type
CFTR channels is reported. The design, synthesis, and biological evaluation
of compounds 7–33 to establish structure–activity
relationships of the scaffold are described, leading to the identification
of clinical development compound icenticaftor (QBW251) 33, which has subsequently progressed to deliver two positive clinical
proofs of concept in patients with CF and COPD and is now being further
developed as a novel therapeutic approach for COPD patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.